Trial intelligence / Profile preview

Effect of diphenhydramine on aggression in the elderly

IRCT20240326061366N2Phase 3Completed

Sponsor
Yasouj University of Medical Sciences
Start
Jul 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of diphenhydramine in delirium, agitation and intermittent explosive disorder (IED), sponsored by Yasouj University of Medical Sciences. Started Jul 2025; status: completed.

02

Drugs

diphenhydramine
03

Conditions

deliriumagitationintermittent explosive disorder (IED)

Beyond the preview

Go deeper on IRCT20240326061366N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20240326061366N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call